Hyrimoz Kit
NDC Package 83457-112-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Hyrimoz (adalimumab-adaz) kits is none. This formulation utilizes a kit delivery system. Marketed by Cordavis Limited, this product is identified by NDC 83457-112 and is authorized under FDA application BLA761071.

Identification & Billing

NDC Package Code
83457-112-01
Package Description
1 KIT in 1 CARTON * 2 SYRINGE in 1 CARTON / .4 mL in 1 SYRINGE * 1 SYRINGE in 1 CARTON / .8 mL in 1 SYRINGE
Product Code
83457-112
11-Digit Billing Format
83457011201
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Hyrimoz
Non-Proprietary Name
Adalimumab-adaz
Dosage Form
Kit - A packaged collection of related material.
Usage Information
None.

Regulatory & Marketing

Labeler Name
Cordavis Limited
Product Type
Human Prescription Drug
FDA Application #
BLA761071
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
12-15-2023
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83457-112-01 identifies a specific commercial package of 1 kit in 1 carton * 2 syringe in 1 carton / .4 ml in 1 syringe * 1 syringe in 1 carton / .8 ml in 1 syringe of Hyrimoz, a human prescription drug labeled by Cordavis Limited. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cordavis Limited on December 15, 2023. The current certification is valid through December 31, 2027.

How is this Cordavis Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83457011201. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83457-112-01
11-Digit CMS (5-4-2)
83457-0112-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.